New drug shows promise in controlling transplant complications
NCT ID NCT03763318
First seen Jun 12, 2026 · Last updated Jun 12, 2026 · Updated 1 time
Summary
This study tested a new drug called EQ001 in 30 people who developed acute graft-versus-host disease (aGVHD) after a stem cell transplant. aGVHD is a serious condition where donor immune cells attack the patient's body. The goal was to see if EQ001 is safe and can help control this immune reaction. Participants received the drug and were monitored for side effects and treatment response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGVHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109-4433, United States
-
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, 33612, United States
-
Intermountain Healthcare
Salt Lake City, Utah, 84103, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
TriStar Centennial Medical Center (SCRI)
Nashville, Tennessee, 53719, United States
-
University of Florida Health Shands Hospital
Gainesville, Florida, 32610, United States
-
University of Miami - Miller School of Medicine
Miami, Florida, 33136, United States
-
University of Michigan - C.S. Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania, Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, 15232, United States
-
Washington University and Barnes Jewish Heart & Vascular Center
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.